Treatment of Corneal Graft Rejection vs Failure

Corneal Graft Rejection: Aggressive Immunosuppression

• The American Academy of Ophthalmology recommends corneal graft rejection treatment with immediate aggressive corticosteroid therapy (topical, periocular, and systemic) to potentially reverse the process 1, 2
• Aggressive corticosteroid therapy using multiple routes of administration is the cornerstone of rejection treatment, with the goal of preventing graft failure 2, 3, 4

Graft Failure: Regrafting as Definitive Management

• Primary graft failure occurs when donor tissue fails to clear within the first 8 weeks postoperatively, often due to inadequate endothelial cell function, and requires regrafting as definitive management 1, 2, 4, 6, 7
• Late graft failure develops years after transplantation due to progressive endothelial cell loss, often accelerated by prior rejection episodes or other factors, and also requires regrafting when visual function deteriorates significantly 1, 2, 7

Key Clinical Distinctions

• Rejection represents an active immunologic process that may respond to aggressive immunosuppression if caught early, whereas graft failure reflects irreversible endothelial dysfunction requiring tissue replacement 2, 4
• The American Academy of Ophthalmology emphasizes the importance of recognizing rejection signs, including epithelial, stromal, and endothelial rejection, to initiate prompt treatment 5

Common Pitfalls to Avoid

• The American Academy of Ophthalmology recommends monitoring all patients on chronic topical corticosteroids for IOP elevation through regular measurements and other assessments 5
• Rejection is the most frequent cause of corneal graft failure overall, making prevention through appropriate long-term immunosuppression and patient education paramount 1, 2, 4